A detailed history of Polar Capital Holdings PLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Polar Capital Holdings PLC holds 2,337,847 shares of CYTK stock, worth $117 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares
2,337,847
Previous 2,454,665 4.76%
Holding current value
$117 Million
Previous $133 Million 7.18%
% of portfolio
0.76%
Previous 0.81%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$51.22 - $60.16 $5.98 Million - $7.03 Million
-116,818 Reduced 4.76%
2,337,847 $123 Million
Q2 2024

Aug 14, 2024

BUY
$47.86 - $75.05 $40.6 Million - $63.7 Million
849,089 Added 52.88%
2,454,665 $133 Million
Q1 2024

May 15, 2024

BUY
$63.75 - $108.06 $12 Million - $20.4 Million
188,522 Added 13.3%
1,605,576 $113 Million
Q4 2023

Feb 14, 2024

SELL
$26.88 - $83.49 $33.3 Million - $103 Million
-1,237,391 Reduced 46.62%
1,417,054 $118 Million
Q2 2023

Dec 13, 2023

BUY
$32.62 - $40.75 $1.39 Million - $1.74 Million
42,753 Added 1.64%
2,654,445 $86.6 Million
Q2 2023

Aug 14, 2023

BUY
$32.62 - $40.75 $1.39 Million - $1.74 Million
42,753 Added 1.64%
2,654,445 $86.6 Million
Q1 2023

Dec 13, 2023

SELL
$33.36 - $45.71 $1.43 Million - $1.95 Million
-42,753 Reduced 1.61%
2,611,692 $91.9 Million
Q1 2023

May 15, 2023

SELL
$33.36 - $45.71 $3.77 Million - $5.17 Million
-113,085 Reduced 4.15%
2,611,692 $91.9 Million
Q4 2022

Feb 14, 2023

BUY
$35.77 - $51.11 $1.9 Million - $2.72 Million
53,129 Added 1.99%
2,724,777 $125 Million
Q3 2022

Nov 14, 2022

SELL
$38.54 - $54.52 $13.7 Million - $19.4 Million
-355,000 Reduced 11.73%
2,671,648 $129 Million
Q2 2022

Aug 15, 2022

SELL
$33.93 - $48.92 $5.25 Million - $7.57 Million
-154,652 Reduced 4.86%
3,026,648 $119 Million
Q1 2022

May 16, 2022

SELL
$29.74 - $46.0 $14.6 Million - $22.6 Million
-490,669 Reduced 13.36%
3,181,300 $117 Million
Q4 2021

Feb 14, 2022

BUY
$34.35 - $46.38 $22.6 Million - $30.5 Million
657,087 Added 21.79%
3,671,969 $167 Million
Q3 2021

Nov 15, 2021

BUY
$18.54 - $35.74 $10.9 Million - $20.9 Million
585,782 Added 24.12%
3,014,882 $108 Million
Q2 2021

Aug 16, 2021

SELL
$19.79 - $26.99 $4.8 Million - $6.55 Million
-242,784 Reduced 9.09%
2,429,100 $48.1 Million
Q1 2021

May 17, 2021

SELL
$18.57 - $25.68 $11.1 Million - $15.4 Million
-600,000 Reduced 18.34%
2,671,884 $62.1 Million
Q4 2020

Feb 16, 2021

BUY
$15.26 - $28.61 $49.9 Million - $93.6 Million
3,271,884 New
3,271,884 $68 Million

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.69B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Polar Capital Holdings PLC Portfolio

Follow Polar Capital Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Polar Capital Holdings PLC with notifications on news.